BioStem Technologies, Inc. (OTC: BSEM) reported Q2 EPS of ($0.03), $1.31 worse than the analyst estimate of $1.28. Revenue for the quarter came in at $49.29 million versus the consensus estimate of $102.3 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.